Drug Shortage Report for TARO-VENLAFAXINE XR

Last updated on 2019-07-06 History
Report ID 11207
Drug Identification Number 02380072
Brand name RAN-VENLAFAXINE XR
Common or Proper name RAN-VENLAFAXINE XR
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 37.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-11-28
Actual start date 2018-11-28
Estimated end date 2019-06-28
Actual end date 2019-07-05
Shortage status Resolved
Updated date 2019-07-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v45 2019-07-06 English Compare
v44 2019-07-05 French Compare
v43 2019-07-05 English Compare
v42 2019-06-24 French Compare
v41 2019-06-24 English Compare
v40 2019-06-07 French Compare
v39 2019-06-07 English Compare
v38 2019-05-28 French Compare
v37 2019-05-28 English Compare
v36 2019-05-13 French Compare
v35 2019-05-13 English Compare
v34 2019-04-29 French Compare
v33 2019-04-29 English Compare
v32 2019-03-22 French Compare
v31 2019-03-22 English Compare
v30 2019-03-04 French Compare
v29 2019-03-04 English Compare
v28 2019-02-15 French Compare
v27 2019-02-15 English Compare
v26 2019-02-11 French Compare

Showing 1 to 20 of 45